Log on / register
Feedback | Support
  Quick Search
BioMed Central
PubMed Central
PubMed





BioMed Central Cancer Gateway

BMC Research highlights

Breast Cancer Research 2008, 10:R41
A new model which can estimate the growth rate of breast cancer, as well as the proportion of tumors detected at screening, shows slower growth rates with increasing age.

Breast Cancer Research 2008, 10:R40
Serum autoantibody profiling is a promising approach for early detection and diagnosis of breast cancer, and a panel of autoantibodies appears preferable to achieve superior accuracy.

Breast Cancer Research 2008, 10:R39
The flavone eupatorin, found in certain plants and used in folk medicine, selectively inhibits the growth of breast carcinoma cells through CYP1 family mediated metabolism, making it a potential chemopreventative candidate.

Breast Cancer Research 2008, 10:R38
A study of over 127,000 women found that NSAIDS do not influence total breast cancer risk, however daily aspirin use appeared to offer some protection against estrogen receptor-positive breast cancer.

BMC Medicine 2008, 6:11
Increased stromal collagen density in mouse mammary tissue increases both tumor formation and tumor cell invasive and migratory properties by three fold; furthermore, a metabolic signature for flavin adenine dinucleotide is identified in invading metastatic cells.


BMC New on Faculty of 1000 Biology
Subscription required, free trial available.






BMC New on Faculty of 1000 Medicine
Subscription required, free trial available.





BMC What we are reading

Cancer Genetics


BMC Resources/Information

Cancer Research UK
National Cancer Institute
 Journals
BMC Cancer
BMC Medical Genomics
Breast Cancer Research
Cancer Cell International
Current Oncology Reports
Current Treatment Options in Oncology
Infectious Agents and Cancer
International Seminars in Surgical Oncology
Journal of Biology
Journal of Carcinogenesis
Molecular Cancer
Radiation Oncology
World Journal of Surgical Oncology

BMC Featured video interview

Professor Ricardo Saban
Professor Ricardo Saban
Health Services Center, University of Oklahoma, USA


BMC Latest research articles

Research
COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
Huan-Ching Chuang, Adel Kardosh, Kevin J Gaffney, Nicos A Petasis, Axel H Schonthal
Molecular Cancer 2008, 7:38 (16May2008)
[Abstract] [Provisional PDF]

Research article
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, Sandy L Nguyen, Anh-Thu Vu, Armando E Giuliano, Dave SB Hoon
Breast Cancer Research 2008, 10:R46 (16May2008)
[Abstract] [Provisional PDF]

Research article
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population
Soroush Nasri, Helen More, Francesco Graziano, Annamaria Ruzzo, Emily Wilson, Anita Dunbier, Cushla McKinney, Tony Merriman, Parry Guilford, Mauro Magnani, Bostjan Humar
BMC Cancer 2008, 8:138 (15May2008)
[Abstract] [Provisional PDF]

Research
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review
Elie A Akl, Frederiek F van Doormaal, Maddalena Barba, Ganesh Kamath, Seo Young Kim, Saskia Kuipers, Saskia Middeldorp, Victor Yosuico, Heather O Dickinson, Holger J Schunemann
Journal of Experimental & Clinical Cancer Research 2008, 27:4 (15May2008)
[Abstract] [Provisional PDF]

Research
Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
Wei Li, Philip T Cagle, Rafael C Botero, John J Liang, Zhaoping Zhang, Dongfeng Tan
Journal of Experimental & Clinical Cancer Research 2008, 27:2 (15May2008)
[Abstract] [Provisional PDF]

Editorial
A new era for Journal of Experimental & Clinical Cancer Research
Mauro Castelli
Journal of Experimental & Clinical Cancer Research 2008, 27:1 (15May2008)
[Abstract] [Provisional PDF]






© 1999-2008 BioMed Central Ltd unless otherwise stated